PMDA drug package insert
スキサメトニウム注40「マルイシ」
PMDA Prescription drug · 丸石製薬株式会社 · package insert May 15, 2023
Key facts
| Brand names | スキサメトニウム注40「マルイシ」, スキサメトニウム注100「マルイシ」 |
|---|---|
| Nonproprietary names | スキサメトニウム塩化物水和物 |
| Companies | 製造販売元／丸石製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 筋弛緩剤 |
| Therapeutic category codes | 871224 |
| YJ codes | 1224400A2050, 1224400A3056 |
| Approval numbers | 22100AMX01790, 22100AMX01791 |
| Package insert edition | 第1版 |
| Package insert date | May 15, 2023 |
| PMDA document key | 730119_1224400A2050_1 |
| PMDA company code | 730119 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: